Comparative bioassay of chlordiazepoxide and amylobarbitone sodium therapies in patients with anxiety states using physiological and clinical measures.
D000654:Amobarbital / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004594:Electrophysiology; D005260:Female; D005712:Galvanic Skin Response; D006309:Hearing; D006801:Humans; D008297:Male; D010919:Placebos; D012867:Skin
D010919:Placebos; D002707:Chlordiazepoxide; D000654:Amobarbital